Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026)
Stoke Therapeutics' (STOK) quarterly Prepaid Assets came in at $6.9 million in Q1 2026, up 36.59% year-on-year from $5.0 million in Q1 2025, and down 21.25% quarter-over-quarter from $8.7 million in Q4 2025.
Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026) Analysis & Trends
Stoke Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 36.59% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 36.59% increase from a year earlier, with the FY2025 full-year figure at $8.7 million, down 21.42% from the prior year.
- Prepaid Assets slipped to $6.9 million in Q1 2026 per STOK's latest filing, from $8.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $13.2 million in Q2 2022 and bottomed at $3.8 million in Q3 2024.
- The 5-year median for Prepaid Assets is $10.7 million (2024), against an average of $9.0 million.
- Across the five-year window, Prepaid Assets slumped 65.17% in 2024 and jumped 103.39% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $10.9 million in 2022, then climbed by 3.55% to $11.3 million in 2023, then slipped by 1.79% to $11.1 million in 2024, then fell by 21.42% to $8.7 million in 2025, then fell by 21.25% to $6.9 million in 2026.
- Per Business Quant, the three latest STOK Prepaid Assets figures stand at $6.9 million (Q1 2026), $8.7 million (Q4 2025), and $7.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.53 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.88 Mn |
| Dec 31, 2025 | 8.74 Mn |
| Sep 30, 2025 | 7.75 Mn |
| Jun 30, 2025 | 6.87 Mn |
| Mar 31, 2025 | 5.04 Mn |
| Dec 31, 2024 | 11.12 Mn |
| Sep 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 11.32 Mn |
| Sep 30, 2023 | 10.94 Mn |
| Jun 30, 2023 | 10.95 Mn |
| Mar 31, 2023 | 5.88 Mn |
| Dec 31, 2022 | 10.93 Mn |
| Sep 30, 2022 | 12.55 Mn |
| Jun 30, 2022 | 13.18 Mn |
| Mar 31, 2022 | 12.29 Mn |
| Dec 31, 2021 | 6.94 Mn |
| Sep 30, 2021 | 8.47 Mn |
| Jun 30, 2021 | 8.61 Mn |